Literature DB >> 19398292

HPLC-MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells.

Margarita Meléndez1, Osvaldo Rosario, Beatriz Zayas, José F Rodríguez.   

Abstract

A sensitive and specific method using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) for the determination of ribavirin monophosphate (RBV-MP) and ribavirin triphosphate (RBV-TP) in cells has been developed and validated. In this method, ribavirin phosphorylated metabolites were extracted and separated by anion exchange solid phase extraction (SPE). The RBV-MP and RBV-TP fractions were dephosphorylated using acid phosphatase and further purified by phenyl boronate SPE prior to HPLC-MS/MS analysis. (13)C(5)-uridine was added as internal standard to obtain better accuracy and precision of the analysis. The MS/MS detector was optimized at multiple reaction monitoring (MRM) using positive electrospray ionization to detect 245-->113 and 250-->133 transitions for ribavirin and internal standard, respectively. The calibration curve was linear over a concentration range of 0.01-10 microg/mL with a limit of quantitation of 0.01 microg/mL. Mean inter-assay accuracy and precision for RBV-MP and RBV-TP quality control samples at 0.03, 0.3 and 8 microg/mL were 5% and 10%, respectively. This method was successfully used for the in vitro determination of RBV-MP and RBV-TP in CEM(ss) cells cultured with RBV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398292      PMCID: PMC4064832          DOI: 10.1016/j.jpba.2009.02.006

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  24 in total

1.  Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.

Authors:  S M Jarvis; J A Thorn; P Glue
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

2.  High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes.

Authors:  M Homma; A L Jayewardene; J Gambertoglio; F Aweeka
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  A sensitive and specific method for the determination of total ribavirin in monkey liver by high-performance liquid chromatography with tandem mass spectrometry.

Authors:  Li-Tain Yeh; Mai Nguyen; David Lourenco; Chin-Chung Lin
Journal:  J Pharm Biomed Anal       Date:  2005-01-19       Impact factor: 3.935

Review 4.  The clinical pharmacology of ribavirin.

Authors:  P Glue
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Sensitive and specific LC-MS/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma.

Authors:  Yifei Liu; Christine Xu; Rongzi Yan; Charmaine Lim; Li-Tain Yeh; Chin-chung Lin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-02-17       Impact factor: 3.205

6.  The metabolism of ribavirin in erythrocytes and nucleated cells.

Authors:  T Page; J D Connor
Journal:  Int J Biochem       Date:  1990

7.  LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells.

Authors:  Li-Tain Yeh; Mai Nguyen; Sohelia Dadgostari; Wei Bu; Chin-Chung Lin
Journal:  J Pharm Biomed Anal       Date:  2006-10-06       Impact factor: 3.935

8.  Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.

Authors:  J F Rodriguez; J L Rodriguez; J Santana; H García; O Rosario
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 9.  Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review.

Authors:  J F Rodriguez Orengo; J Santana; I Febo; C Diaz; J L Rodriguez; R Garcia; E Font; O Rosario
Journal:  P R Health Sci J       Date:  2000-03       Impact factor: 0.705

10.  Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.

Authors:  Margarita Meléndez; Raúl Blanco; Wilfredo Delgado; Rosario García; Jorge Santana; Hermes García; Osvaldo Rosario; José F Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

View more
  4 in total

1.  Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir.

Authors:  Manel Aouri; Darius Moradpour; Matthias Cavassini; Thomas Mercier; Thierry Buclin; Chantal Csajka; Amalio Telenti; Andri Rauch; Laurent A Decosterd
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

2.  Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantification.

Authors:  Leah C Jimmerson; Michelle L Ray; Lane R Bushman; Peter L Anderson; Brandon Klein; Joseph E Rower; Jia-Hua Zheng; Jennifer J Kiser
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-12-17       Impact factor: 3.205

Review 3.  'Borono-lectin' based engineering as a versatile platform for biomedical applications.

Authors:  Akira Matsumoto; Yuji Miyahara
Journal:  Sci Technol Adv Mater       Date:  2017-12-19       Impact factor: 8.090

4.  Fast Determination of Ingredients in Solid Pharmaceuticals by Microwave-Enhanced In-Source Decay of Microwave Plasma Torch Mass Spectrometry.

Authors:  Rui Su; Xinchen Wang; Changming Hou; Meiling Yang; Keke Huang; Huanwen Chen
Journal:  J Am Soc Mass Spectrom       Date:  2017-06-19       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.